Jane Street
ORGO icon

Jane Street’s Organogenesis Holdings ORGO Stock Holding History

Jane Street’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,800
Closed -$120K – 10522
2022
Q1 		$120K Buy
+15,800
New +$122K ﹤0.01% 9363
2021
Q4 		– Sell
-24,900
Closed -$355K – 10618
2021
Q3 		$355K Buy
+24,900
New +$387K ﹤0.01% 7867

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Jane Street's ORGO Position: Q1 2026 in Review

Jane Street reduced its Organogenesis Holdings (ORGO) stake by 85% in Q1 2026, selling an estimated $2.61M and leaving 129,333 shares worth $307K. The position accounts for ﹤0.01% of the portfolio, ranked #9188.

Jane Street first reported a position in ORGO in Q2 2020 and has held it in 15 quarters since. The position peaked at $4.57M in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Jane Street held 129,333 shares of Organogenesis Holdings worth $307K as of Q1 2026.
  • Jane Street sold 752,354 Organogenesis Holdings shares in Q1 2026, an estimated $2.61M.
  • Organogenesis Holdings made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #9188 holding.
  • Jane Street first reported a position in Organogenesis Holdings in Q2 2020 and has held it in 15 quarters since.
  • Jane Street's Organogenesis Holdings position peaked at $4.57M in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.